Biomarker Discovery & Development | Whitepapers & Reports
          
          Inoviv-Charité Predictive COVID-19 Disease Severity Test
            
              28 February 2023
            
          
           
        This predictive biomarker signature was identified through proteome screening of thousands of patient samples at Charité University Hospital with longitudinal follow up.
Subscribe to our newsletter
    
    Sign up for our monthly Newsletter to keep up with all things Precision Medicine
  
        

 
             
             
             
             
                             
                                
                               
       
      